logo

Neovasc Inc. (NVCN)



Trade NVCN now with
  Date
  Headline
1/29/2019 7:34:59 AM Neovasc Receives Approval To Proceed With Phase 2 Of TIARA-II Study From Clinical Regulators In Germany And The UK
1/22/2019 7:31:14 AM Neovasc Reports Dismissal Of Claim Brought By Edwards Lifesciences
12/11/2018 7:33:32 AM Neovasc Announces Positive 12-year Follow-up Data For Neovasc Reducer™ As Published In JACC
10/10/2018 7:33:41 AM Neovasc Reducer Granted Breakthrough Device Designation From FDA
10/9/2018 2:20:57 PM Neovasc Regains Compliance With Nasdaq Minimum Bid Price Rule
10/3/2018 7:32:15 AM Neovasc Announces Positive 12-week Follow-up Data From First U.S. Patient Implanted With Neovasc Reducer™
9/11/2018 7:31:55 AM Neovasc Reports Extension To Regain Compliance With Nasdaq Minimum Bid Price Rule
9/11/2018 7:22:26 AM Neovasc Provides Initial Comments On Lawsuit Filed By Endovalve
8/6/2018 7:32:57 AM Neovasc Reports Publication Of Safety, Efficacy Results From REDUCE Study In International Journal Of Cardiology
7/2/2018 7:35:43 AM Tiara And Reducer Featured At CSI Frankfurt 2018
6/20/2018 7:32:33 AM Neovasc Reports First Implant Of Neovasc Reducer In U.S. Patient